Prognostic factors in definitive radiotherapy of uterine cervical cancer

European Journal of Gynaecological Oncology

Volumn 24, Issue 3-4, 2003, Pages 309-314

  Yalman, D ^a,d   Aras, A B ^a   Ozkok S ^a   Duransoy, A ^b   Celik O K ^c   Ozsaran Z ^a   Haydaroglu A ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b Ataturk State Hospital   (Turkey)

^c CELAL BAYAR UNIVERSITY MEDICAL FACULTY   (Turkey)

^d EGE UNIVERSITY   (Turkey)

Author keywords

External radiotherapy; High dose rate brachytherapy; Prognostic factors; Uterine cervical cancer

Indexed keywords

ANTINEOPLASTIC AGENT; HEMOGLOBIN;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; DISEASE COURSE; FEMALE; HEMOGLOBIN DETERMINATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MEDICAL RECORD; MULTIVARIATE ANALYSIS; PROGNOSIS; RADIATION DOSE; RETROSPECTIVE STUDY; REVIEW; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME; TREATMENT FAILURE; TREATMENT OUTCOME; UTERINE CERVIX CANCER;

ADENOCARCINOMA; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BIOPSY, NEEDLE; BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROBABILITY; PROGNOSIS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 0038014001     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Swift P.S.: "Carcinoma of the uterine cervix". In: Textbook of Radiation Oncology, Leibel S.A., Philips T.L. (eds.). Philadelphia, W. B. Saunders, 1998, 799.
2. Keys H.M., Bundy B.N., Stehman F.B. et al.: "Cisplatin, radiation and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma". N. Eng. J. Med., 1999, 340, 1154.
3. Whitney C.W., Sause W., Bundy B.N. et al.: "A randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stages IIB-IVA carcinoma of the cervix with negative paraaortic lymph nodes. A Gynecologic Oncology Group and Southwest Oncology Group Study". J. Clin. Oncol., 1999, 17, 1339.
4. Rose P.G., Bundy B.N., Watkins E.B. et al.: "Concurrent cisplatin-based chemoradiation in locally advanced cervical cancer". N. Eng. J. Med., 1999, 340, 1144.
5. Morris M., Eifel P.J., Lu J. et al.: "Pelvic radiation with concurrent chemotherapy versus pelvic and para-aortic radiation for high-risk cervical cancer. A randomized Radiation Therapy Oncology Group clinical trial". N. Eng. J. Med., 1999, 340, 1137.
6. Peters W.A., III, Liu P.Y., Barrett R.J. et al.: "Cisplatin and 5-fluorouracil plus radiation therapy are superior to radiation therapy as adjunctive in high-risk early-stage carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: Report of a phase III intergroup study". Gynecol. Oncol., 1999, 72, 443.
7. Fyles A.W., Pintilie M., Kirkbride P., Levin W., Manchul L.A., Rawlings G.A.: "Prognostic factors in patients with cervix cancer treated by radiation therapy: results of a multiple regression analysis". Radiother. Oncol., 1995, 35 (2), 107.
8. Lanciano R.M., Martz K., Montana G.S., Hanks G.E.: "Influence of age, prior abdominal surgery, fraction size and dose on for squamous cell cancer of the uterine cervix. A patterns of care study". Cancer, 1992, 69 (8), 2124.
9. Meanwell C.A., Kelly K.A., Wilson S. et al.: "Young age as a prognostic factor in cervical cancer: Analysis of population based data from 10,022 cases". Br. Med. J. Clin. Res. Ed., 1988, 296 (6619), 386.
10. Prempree T., Patanaphan V., Sewchand W., Scott R.M.: "The influence of patients' age and tumor grade on the prognosis of carcinoma of the cervix". Cancer, 1983, 51, 1764.
11. Delaloye J.F., Pampallona S., Coucke P.A., De Grandi P.: "Younger age as a bad prognostic factor in patients with carcinoma of the cervix". Eur. J. Obstet. Gynecol. Reprod. Biol., 1996, 64 (2), 201.
12. Girinsky T., Pejovic-Lenfant M.H., Bourhis J. et al.: "Prognostic value of hemoglobin concentrations and blood transfusions in advanced carcinoma of cervix treated by radiation therapy: Results of a retrospective study of 386 patients". Int. J. Radiat. Oncol. Biol. Phys., 1989, 16 (1), 37.
13. Takeshi K., Katsuyuki K., Yoshiaki T. et al.: "Definitive radiotherapy combined with high-dose-rate brachytherapy for stage III carcinoma of the uterine cervix: Retrospective analysis of prognostic factors concerning patient characteristics and treatment parameters". Int. J. Radiat. Oncol. Biol. Phys., 1998, 41 (2), 319.
14. Stehman F.B., Bundy B.N., DiSaia P.J., Keys H.M., Larson J.E., Fowler W.C.: "Carcinoma of the cervix treated with radiation therapy I. A multi-variate analysis of prognostic variables in the Gynecologic Oncology Group". Cancer, 1991, 67, 2776.
15. Delaloye J.F., Coucke P.A., Pampallona S., De Grandi P.: "Effect of total treatment time on event free survival in carcinoma of the cervix". Gynecol. Oncol., 1996, 60 (1), 42.
16. Fyles A., Keane T.J., Barton M., Simm J.: "The effect of treatment duration in the local control of cervix cancer". Radiother. Oncol., 1992, 25 (4), 273.
17. Girinsky T., Rey A., Roche B. et al.: "Overall treatment time in advanced cervical carcinomas: A critical parameter in treatment outcome". Int. J. Radiat. Oncol. Biol. Phys., 1993, 27 (5), 1051.
18. Kim R.Y., Trotti A., Wu C.J., Soong S.J., Salter M.M.: "Radiation alone in the treatment of cancer of the uterine cervix: Analysis of pelvic failure and dose response relationship". Int. J. Radiat. Oncol. Biol. Phys., 1989, 17 (5), 973.
19. Lanciano R.M., Pajak T.F., Martz K., Hanks G.H.: "The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: A patterns of care study". Int. J. Radiat. Oncol. Biol. Phys., 1993, 25 (3), 391.
20. Perez C.A., Grigsby P.W., Chao K.S.C., Mutch D.G., Lockett M.A.: "Tumor size, irradiation dose and long-term outcome of carcinoma of uterine cervix". Int. J. Radiat. Oncol. Biol. Phys., 1998, 41 (2), 307.
21. Toita T., Nakano M., Higashi M., Sakumoto K., Kanazawa K.: "Prognostic value of cervical size and pelvic lymph node status assessed by computed tomography for patients with uterine cervical cancer treated by radical radiation therapy". Int. J. Radiat. Oncol. Biol. Phys., 1995, 33 (4), 843.
22. Horiot J.C., Pigneux J., Pourquier H. et al.: "Radiotherapy alone in carcinoma of intact uterine cervix according to Fletcher guidelines: A French cooperative study of 1383 cases". Int. J. Radiat. Oncol. Biol. Phys., 1988, 14, 605.
23. Barillot I., Horiot J.C., Pigneux J. et al.: "Carcinoma of the intact uterine cervix treated with radiotherapy alone: A French Cooperative study: Update and multivariate analysis of prognostic factors". Int. J. Radiat. Oncol. Biol. Phys., 1997, 38 (5), 969.
24. Montana G.S., Fowler W.C., Varia M.A. et al.: "Carcinoma of the cervix, stage III. Results of radiation therapy". Cancer, 1986, 57, 148.
25. Kim R.Y., Trotti A., Wu C.J., Soong S.J., Salter M.M.: "Radiation alone in treatment of cancer of the uterine cervix: Analysis of pelvic failure and dose response relationship". Int. J. Radiat. Oncol. Biol. Phys., 1989, 17 (5), 973.
26. Berek J.S., Castaldo T.W., Hacker N.F., Petrilli E.S., Lagasse L.D., Moore J.G.: "Adenocarcinoma of the uterine cervix". Cancer; 1981, 48, 2734.
27. Eifel P.J., Morris M., Oswald M.J., Wharton J.T., Delclos L.: "Adenocarcinoma of the uterine cervix. Prognosis and patterns of failure in 367 cases". Cancer, 1990, 65, 2507.
28. Nakano T., Arai T., Morita S., Oka K.: "Radiation therapy alone for adenocarcinoma of the uterine cervix". Int. J. Radiat. Oncol. Biol. Phys., 1995, 32 (5), 1331.
29. Fagundes, Grigsby P.W., Perez C.A., Kuske R.R. et al.: "Adenocarcinoma of the uterine cervix: Lack of evidence for a poor prognosis". Radiother. Oncol., 1988, 12, 289.
30. Kapp K.S., Stuecklschweiger G.F., Kapp D.S. et al.: "Prognostic factors in patients with carcinoma of the uterine cervix treated with external beam irradiation and Ir-192 High-Dose-Rate brachytherapy". Int. J. Radiat. Oncol. Biol. Phys., 1998, 42 (3), 531.
31. Dusenbery K.E., McGuire W.A., Holt P.J. et al.: "Erythropoietin increases hemoglobin during radiation therapy for cervical cancer". Int. J. Radiat. Oncol. Biol. Phys., 1994, 29 (5), 1079.
32. Lanciano R.M., Martz K., Coia L.R., Hanks G.E.: "Tumor and treatment factors improving outcome in stage IIIB cervix cancer". Int. J. Radiat. Oncol. Biol. Phys., 1991, 20 (1), 95.
33. Perez C.A., Grigsby P.W., Castro-vita H., Lockett M.A.: "Carcinoma of the uterine cervix I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy". Int. J. Radiat. Oncol. Biol. Phys., 1995, 32 (5), 1275.
34. Chatani M., Matayoshi Y., Masaki N., Inoue T.: "High-dose-rate intracavitary irradiation for carcinoma of the uterine cervix. The adverse effect of treatment prolongation". Strahlenter. Onkol., 1997, 173 (7), 379.
35. Delaloye J.F., Couche P.A., Pampallona S., Peltecu G., DeGrandi P.: "Radiation therapy duration influences overall survival in patients with cervical carcinoma". Int. J. Gynecol. Obstet., 1997, 57 (3), 295.
36. Nag S., Erickson B., Thomadsen B., Orton C., Demones J.D,. Petereit D.: "The American Brachytherapy Society Recommendations for high-dose-rate brachytherapy for carcinoma of the cervix". Int. J. Radiat. Oncol. Biol. Phys., 2000, 48 (1), 201.
37. Perez C.A., Breaux S., Madoc-Jones H. et al.: "Radiation therapy alone in the treatment of carcinoma of uterine cervix I. Analysis of tumor recurrence". Cancer, 1983, 51, 1393.
38. Komaki R., Brickner T., Hanlon A.L., Owen J.B., Hanks G.E.: "Long-term results of treatment of cervical carcinoma in the United States in 1973, 1978 and 1983: Patterns of Care Study (PCS)". Int. J. Radiat. Oncol. Biol. Phys., 1995, 31 (4), 973.
39. Marcial L.V., Marcial V.A., Krall J.M., Lanciano R.M., Coia L.R., Hanks G.E.: "Comparison of 1 vs. 2 or more intracavitary applications in the management of carcinoma of the cervix with radiation alone. A Patterns of Care Report". Int. J. Radiat. Oncol. Biol. Phys., 1991, 20, 81.
40. Logsdon M.D., Eifel P.J.: "FIGO IIIB squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy". Int. J. Radiat. Oncol. Biol. Phys., 1999, 43 (4), 763.
41. Chiara S., Bruzzone M., Merlini L. et al.: "Randomized study comparing chemotherapy plus radiotherapy versus radiotherapy alone in FIGO stage IIB-III cervical carcinoma. GONO (North-West Oncologic Cooperative Group)". Am. J. Clin. Oncol., 1994, 17 (49), 294.
42. Christie D.R.H., Bull C.A., Gebski V., Langlands A.O.: "Concurrent 5-fluorouracil, mitomycin C and irradiation in locally advanced cervix cancer". Radiother. Oncol., 1995, 37, 181.
43. Denehy T.R., Eastman R., SanFlippo L., Gregori C.A., Breen J.L.: "Bolus mitomycin C and 5-FU with sequential radiation for poorprognosis locally advanced cervical cancer". Gynecol. Oncol., 1996, 60, 64.
44. Sundfor K., Trope C.G., Högberg T. et al.: "Radiotherapy and neoadjuvant chemotherapy for cervical carcinoma. A randomized multicenter study of sequential cisplatin and 5-fluorouracil and radiotherapy in advanced cervical carcinoma stage 3B and 4A". Cancer, 1996, 77, 2371.
45. Fagundes H., Perez C.A., Grigsby P.W., Lockett M.A.: "Distant metastases after irradiation alone in carcinoma of the uterine cervix". Int. J. Radiat. Oncol. Biol. Phys., 1992, 24 (2), 197.
46. Podczaski E., Stryker J.A., Kaminski P. et al.: "Extended-field radiation therapy for carcinoma of the cervix". Cancer, 1990, 66, 251.